BET bromodomain inhibitor 3
BET bromodomain inhibitor 3 is BET bromodomain inhibitor. BET bromodomain inhibitor 3 has inhibitory effect against BrdT with Ki value of > 40 µM. BET bromodomain inhibitor 3 can be used for the research of contraception, cancer, and heart disease[1].
Product Specifications
CAS Number
854137-39-6
UNSPSC
12352005
Hazard Statement
H302-H315-H319
Target
Epigenetic Reader Domain
Type
Reference compound
Related Pathways
Epigenetics
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/bet-bromodomain-inhibitor-3.html
Purity
97.0
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
O=C1OCC2=C1C(C3=CC=C(C)C=C3)C(C(N(C)C(N4C)=O)=O)=C4N2
Molecular Formula
C18H17N3O4
Molecular Weight
339.35
Precautions
P264-P270-P280-P302+P352-P305+P351+P338-P330-P362+P364-P501
References & Citations
[1]Ayoub AM, et al. BET Bromodomain Inhibitors with One-Step Synthesis Discovered from Virtual Screen [published correction appears in J Med Chem. 2017 Jul 27;60 (14) :6458]. J Med Chem. 2017;60 (12) :4805-4817.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC880008-100 1x 100 µL
MAGE A1 (MA454), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC470031-100 1x 100 µL
Mucin 5AC (MUC5AC) (45M1), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC040965-500 1x 500 µL
MUC1 / CA15-3 / EMA / CD227 (Epithelial Marker) (VU-11D1), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC400948-500 1x 500 µL
Cytokeratin 5/8 (C-50), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC880779-500 1x 500 µL
CD30 (Ki-1/779), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details